30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Biolife Solutions Inc (BLFS)

Track

Over the last 90 days, Biolife Solutions Inc. has seen significant insider selling, with a net value of -$28.1 million. The majority of this activity stems from Casdin Partners Master Fund, L.P., a 10% shareholder, which executed several large sell transactions. Other officers also engaged in smaller planned sales.
Stock chart
Ticker: BLFS Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Casdin Partners Master Fund, L.P.
10% Shareholder
2 sales — total 31,005,000 USD
Proposed sale 21 May 2026
Value US$3,955,260.42 | Price 44.55 | Shares 96,045
Sale 21 May 2026
Value US$4,837,095.13 | Price 56.30 | Shares 98,929
Sale 20 May 2026
Value US$4,309,645.02 | Price 365.95 | Shares 27,477
Proposed sale 20 May 2026
Value US$6,000,000.00 | Price 24.00 | Shares 250,000
Sale 19 May 2026
Value US$6,795,000.00 | Price 22.65 | Shares 300,000
Proposed sale 19 May 2026
Value US$6,690,000.00 | Price 22.30 | Shares 300,000
Planned sale 23 Mar 2026
Value US$49,401.09 | Price 19.17 | Shares 2,577
Proposed sale 23 Mar 2026
Value US$48,576.45 | Price 18.85 | Shares 2,577
Sale 9 Mar 2026
Value US$10,000.00 | Price 20.00 | Shares 500
Proposed sale 9 Mar 2026
Value US$9,930.00 | Price 19.86 | Shares 500
Sale 5 Mar 2026
Value US$1,952,998.45 | Price 20.15 | Shares 96,923
Proposed sale 5 Mar 2026
Value US$2,003,398.41 | Price 20.67 | Shares 96,923
Planned sale 3 Mar 2026
Value US$2,302.14 | Price 20.74 | Shares 111
Planned sale 3 Mar 2026
Value US$10,971.46 | Price 20.74 | Shares 529
Planned sale 3 Mar 2026
Value US$4,542.06 | Price 20.74 | Shares 219
Planned sale 3 Mar 2026
Value US$8,669.32 | Price 20.74 | Shares 418
Planned sale 3 Mar 2026
Value US$7,321.22 | Price 20.74 | Shares 353
Planned sale 3 Mar 2026
Value US$12,195.12 | Price 20.74 | Shares 588
Planned sale 6 Jan 2026
Value US$10,363.95 | Price 25.59 | Shares 405
Planned sale 6 Jan 2026
Value US$8,572.65 | Price 25.59 | Shares 335
Planned sale 6 Jan 2026
Value US$25,334.10 | Price 25.59 | Shares 990
Planned sale 6 Jan 2026
Value US$8,802.96 | Price 25.59 | Shares 344
Planned sale 6 Jan 2026
Value US$6,167.19 | Price 25.59 | Shares 241
Sale 15 Dec 2025
Value US$17,439.98 | Price 24.46 | Shares 713
Sale 15 Dec 2025
Value US$49,200.00 | Price 24.60 | Shares 2,000
Proposed sale 15 Dec 2025
Value US$17,390.07 | Price 24.39 | Shares 713
Planned sale 9 Dec 2025
Value US$13,042.47 | Price 25.13 | Shares 519
Planned sale 9 Dec 2025
Value US$5,855.29 | Price 25.13 | Shares 233
Planned sale 9 Dec 2025
Value US$8,996.54 | Price 25.13 | Shares 358
Planned sale 9 Dec 2025
Value US$25,959.29 | Price 25.13 | Shares 1,033
Planned sale 9 Dec 2025
Value US$15,857.03 | Price 25.13 | Shares 631
Sale 4 Dec 2025
Value US$771,600.00 | Price 25.72 | Shares 30,000
Proposed sale 4 Dec 2025
Value US$771,504.00 | Price 25.72 | Shares 30,000
Sale 26 Nov 2025
Value US$54,000.00 | Price 27.00 | Shares 2,000
Planned sale 25 Nov 2025
Value US$15,616.16 | Price 26.74 | Shares 584
Planned sale 25 Nov 2025
Value US$11,097.10 | Price 26.74 | Shares 415
Planned sale 25 Nov 2025
Value US$5,802.58 | Price 26.74 | Shares 217
Planned sale 25 Nov 2025
Value US$2,941.40 | Price 26.74 | Shares 110
Planned sale 25 Nov 2025
Value US$9,385.74 | Price 26.74 | Shares 351
Sale 25 Nov 2025
Value US$54,000.00 | Price 27.00 | Shares 2,000
Planned sale 25 Nov 2025
Value US$14,065.24 | Price 26.74 | Shares 526
Sale 21 Nov 2025
Value US$26,000.00 | Price 26.00 | Shares 1,000
Sale 20 Nov 2025
Value US$110,858.73 | Price 24.51 | Shares 4,523
Sale 19 Nov 2025
Value US$11,686.50 | Price 24.50 | Shares 477
Proposed sale 13 Nov 2025
Value US$789,297.26 | Price 25.33 | Shares 31,165
Sale 13 Nov 2025
Value US$789,409.45 | Price 25.33 | Shares 31,165
Sale 12 Nov 2025
Value US$864,857.84 | Price 25.88 | Shares 33,418
Proposed sale 12 Nov 2025
Value US$316,560.00 | Price 26.38 | Shares 12,000
Proposed sale 12 Nov 2025
Value US$864,994.85 | Price 25.88 | Shares 33,418
Sale 11 Nov 2025
Value US$926,154.55 | Price 26.15 | Shares 35,417
Proposed sale 11 Nov 2025
Value US$926,090.80 | Price 26.15 | Shares 35,417
Planned sale 24 Oct 2025
Value US$48,297.34 | Price 28.99 | Shares 1,666
Planned sale 22 Oct 2025
Value US$1,031,803.50 | Price 27.30 | Shares 37,795
Proposed sale 22 Oct 2025
Value US$1,031,807.28 | Price 27.30 | Shares 37,795
Planned sale 20 Oct 2025
Value US$7,650.50 | Price 27.82 | Shares 275
Proposed sale 16 Oct 2025
Value US$278,910.00 | Price 30.99 | Shares 9,000
Sale 15 Oct 2025
Value US$21,410,325.00 | Price 28.55 | Shares 750,000
Proposed sale 15 Oct 2025
Value US$21,410,325.00 | Price 28.55 | Shares 750,000
Planned sale 9 Oct 2025
Value US$7,907.04 | Price 27.36 | Shares 289
Planned sale 9 Oct 2025
Value US$22,790.88 | Price 27.36 | Shares 833
Planned sale 9 Oct 2025
Value US$13,926.24 | Price 27.36 | Shares 509
Planned sale 9 Oct 2025
Value US$5,143.68 | Price 27.36 | Shares 188
Planned sale 9 Oct 2025
Value US$11,463.84 | Price 27.36 | Shares 419
Planned sale 15 Sep 2025
Value US$18,285.54 | Price 25.61 | Shares 714
Proposed sale 15 Sep 2025
Value US$18,214.14 | Price 25.51 | Shares 714
Planned sale 11 Sep 2025
Value US$9,605.14 | Price 26.83 | Shares 358
Planned sale 11 Sep 2025
Value US$13,710.13 | Price 26.83 | Shares 511
Planned sale 11 Sep 2025
Value US$1,931.76 | Price 26.83 | Shares 72
Planned sale 11 Sep 2025
Value US$6,251.39 | Price 26.83 | Shares 233
Planned sale 11 Sep 2025
Value US$27,688.56 | Price 26.83 | Shares 1,032
Planned sale 11 Sep 2025
Value US$16,902.90 | Price 26.83 | Shares 630
Planned sale 26 Aug 2025
Value US$5,571.36 | Price 25.44 | Shares 219
Planned sale 26 Aug 2025
Value US$10,506.72 | Price 25.44 | Shares 413
Planned sale 26 Aug 2025
Value US$13,508.64 | Price 25.44 | Shares 531
Planned sale 26 Aug 2025
Value US$9,005.76 | Price 25.44 | Shares 354
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-21 2026-05-21 PrS Proposed sale
3.3
Casdin Partners Master Fund, L.P.

10% Shareholder

Large shareholder
96,045
44.55
US$3,955,260 		96,045 44.55 US$3,955,260
2026-05-21 2026-05-21 S Sale
3.3
Casdin Partners Master Fund, L.P.
Large shareholder
98,929 -19.9%
56.30
US$4,837,095 		98,929 -19.9% 56.30 US$4,837,095
2026-05-21 2026-05-20 S Sale
3.3
Casdin Partners Master Fund, L.P.
Large shareholder
27,477 +2.3%
365.95
US$4,309,645 		27,477 +2.3% 365.95 US$4,309,645
2026-05-20 2026-05-20 PrS Proposed sale
3.3
Casdin Partners Master Fund, L.P

10% Shareholder

Large shareholder
250,000
24.00
US$6,000,000 		250,000 24.00 US$6,000,000
2026-05-21 2026-05-19 S Sale
3.3
Casdin Partners Master Fund, L.P.
Large shareholder
300,000 -5.0%
22.65
US$6,795,000 		300,000 -5.0% 22.65 US$6,795,000
2026-05-19 2026-05-19 PrS Proposed sale
3.3
Casdin Partners Master Fund, L.P.

10% Shareholder

Large shareholder
300,000
22.30
US$6,690,000 		300,000 22.30 US$6,690,000
2026-03-31 2026-03-23 PlS Planned sale
3.0
Foster Karen A.

Chief Quality and Operations

Officer
2,577 -2.3%
19.17
US$49,401 		2,577 -2.3% 19.17 US$49,401
2026-03-23 2026-03-23 PrS Proposed sale
3.0
KAREN FOSTER

Officer

Officer
2,577
18.85
US$48,576 		2,577 18.85 US$48,576
2026-03-09 2026-03-09 S Sale
3.0
Foster Karen A.

Chief Quality and Operations

Officer
500 -0.4%
20.00
US$10,000 		500 -0.4% 20.00 US$10,000
2026-03-09 2026-03-09 PrS Proposed sale
3.0
KAREN FOSTER

Officer

Officer
500
19.86
US$9,930 		500 19.86 US$9,930
2026-03-09 2026-03-05 S Sale
3.0
Foster Karen A.

Chief Quality and Operations

Officer
96,923 -46.0%
20.15
US$1,952,998 		96,923 -46.0% 20.15 US$1,952,998
2026-03-05 2026-03-05 PrS Proposed sale
3.0
KAREN FOSTER

Officer

Officer
96,923
20.67
US$2,003,398 		96,923 20.67 US$2,003,398
2026-03-05 2026-03-03 PlS Planned sale
Werner Sean

Chief Technology Officer

Officer
111 -0.2%
20.74
US$2,302 		111 -0.2% 20.74 US$2,302
2026-03-05 2026-03-03 PlS Planned sale
3.4
Mathew Aby J.

EVP & Chief Scientific Officer

Officer
529 -0.1%
20.74
US$10,971 		529 -0.1% 20.74 US$10,971
2026-03-05 2026-03-03 PlS Planned sale
3.6
Aebersold Sarah

Chief Human Resources Officer

Officer
219 -0.2%
20.74
US$4,542 		219 -0.2% 20.74 US$4,542
2026-03-05 2026-03-03 PlS Planned sale
3.0
Foster Karen A.

Chief Quality and Operations

Officer
418 -0.2%
20.74
US$8,669 		418 -0.2% 20.74 US$8,669
2026-03-05 2026-03-03 PlS Planned sale
2.9
Berard Todd

Chief Marketing Officer

Officer
353 -0.2%
20.74
US$7,321 		353 -0.2% 20.74 US$7,321
2026-03-05 2026-03-03 PlS Planned sale
4.0
Wichterman Troy

Chief Financial Officer

Officer
588 -0.3%
20.74
US$12,195 		588 -0.3% 20.74 US$12,195
2026-01-08 2026-01-06 PlS Planned sale
3.4
Mathew Aby J.

EVP & Chief Scientific Officer

Officer
405 -0.1%
25.59
US$10,364 		405 -0.1% 25.59 US$10,364
2026-01-08 2026-01-06 PlS Planned sale
3.0
Foster Karen A.

Chief Quality and Operations

Officer
335 -0.2%
25.59
US$8,573 		335 -0.2% 25.59 US$8,573
2026-01-08 2026-01-06 PlS Planned sale
4.0
Wichterman Troy

Chief Financial Officer

Officer
990 -0.7%
25.59
US$25,334 		990 -0.7% 25.59 US$25,334
2026-01-08 2026-01-06 PlS Planned sale
2.9
Berard Todd

Chief Marketing Officer

Officer
344 -0.3%
25.59
US$8,803 		344 -0.3% 25.59 US$8,803
2026-01-08 2026-01-06 PlS Planned sale
3.6
Aebersold Sarah

Chief Human Resources Officer

Officer
241 -0.3%
25.59
US$6,167 		241 -0.3% 25.59 US$6,167
2025-12-17 2025-12-15 S Sale
3.6
Aebersold Sarah

Chief Human Resources Officer

Officer
713 -0.9%
24.46
US$17,440 		713 -0.9% 24.46 US$17,440
2025-12-17 2025-12-15 S Sale
3.1
DuRoss Amy
Non-Executive Director
2,000 -9.7%
24.60
US$49,200 		2,000 -9.7% 24.60 US$49,200
2025-12-15 2025-12-15 PrS Proposed sale
3.6
SARAH AEBERSOLD

Officer

Officer
713
24.39
US$17,390 		713 24.39 US$17,390
2025-12-17 2025-12-09 PlS Planned sale
3.0
Foster Karen A.

Chief Quality and Operations

Officer
519 -0.3%
25.13
US$13,042 		519 -0.3% 25.13 US$13,042
2025-12-17 2025-12-09 PlS Planned sale
3.6
Aebersold Sarah

Chief Human Resources Officer

Officer
233 -0.3%
25.13
US$5,855 		233 -0.3% 25.13 US$5,855
2025-12-17 2025-12-09 PlS Planned sale
2.9
Berard Todd

Chief Marketing Officer

Officer
358 -0.3%
25.13
US$8,997 		358 -0.3% 25.13 US$8,997
2025-12-17 2025-12-09 PlS Planned sale
4.0
Wichterman Troy

Chief Financial Officer

Officer
1,033 -0.7%
25.13
US$25,959 		1,033 -0.7% 25.13 US$25,959
2025-12-17 2025-12-09 PlS Planned sale
3.4
Mathew Aby J.

EVP & Chief Scientific Officer

Officer
631 -0.2%
25.13
US$15,857 		631 -0.2% 25.13 US$15,857
2025-12-05 2025-12-04 S Sale
4.0
Wichterman Troy

Chief Financial Officer

Officer
30,000 -16.4%
25.72
US$771,600 		30,000 -16.4% 25.72 US$771,600
2025-12-04 2025-12-04 PrS Proposed sale
4.0
TROY WICHTERMAN

Officer

Officer
30,000
25.72
US$771,504 		30,000 25.72 US$771,504
2025-11-28 2025-11-26 S Sale
3.1
DuRoss Amy
Non-Executive Director
2,000 -8.8%
27.00
US$54,000 		2,000 -8.8% 27.00 US$54,000
2025-11-28 2025-11-25 PlS Planned sale
4.0
Wichterman Troy

Chief Financial Officer

Officer
584 -0.3%
26.74
US$15,616 		584 -0.3% 26.74 US$15,616
2025-11-28 2025-11-25 PlS Planned sale
3.0
Foster Karen A.

Chief Quality and Operations

Officer
415 -0.2%
26.74
US$11,097 		415 -0.2% 26.74 US$11,097
2025-11-28 2025-11-25 PlS Planned sale
3.6
Aebersold Sarah

Chief Human Resources Officer

Officer
217 -0.3%
26.74
US$5,803 		217 -0.3% 26.74 US$5,803
2025-11-28 2025-11-25 PlS Planned sale
Werner Sean

Chief Technology Officer

Officer
110 -0.4%
26.74
US$2,941 		110 -0.4% 26.74 US$2,941
2025-11-28 2025-11-25 PlS Planned sale
2.9
Berard Todd

Chief Marketing Officer

Officer
351 -0.3%
26.74
US$9,386 		351 -0.3% 26.74 US$9,386
2025-11-28 2025-11-25 S Sale
3.1
DuRoss Amy
Non-Executive Director
2,000 -8.1%
27.00
US$54,000 		2,000 -8.1% 27.00 US$54,000
2025-11-28 2025-11-25 PlS Planned sale
3.4
Mathew Aby J.

EVP & Chief Scientific Officer

Officer
526 -0.1%
26.74
US$14,065 		526 -0.1% 26.74 US$14,065
2025-11-21 2025-11-21 S Sale
3.1
DuRoss Amy
Non-Executive Director
1,000 -3.9%
26.00
US$26,000 		1,000 -3.9% 26.00 US$26,000
2025-11-21 2025-11-20 S Sale
3.1
DuRoss Amy
Non-Executive Director
4,523 -15.0%
24.51
US$110,859 		4,523 -15.0% 24.51 US$110,859
2025-11-21 2025-11-19 S Sale
3.1
DuRoss Amy
Non-Executive Director
477 -1.6%
24.50
US$11,686 		477 -1.6% 24.50 US$11,686
2025-11-13 2025-11-13 PrS Proposed sale
3.7
RODERICK DE GREEF

Officer

Officer
31,165
25.33
US$789,297 		31,165 25.33 US$789,297
2025-11-13 2025-11-13 S Sale
3.7
DE GREEF RODERICK

President and CEO

Executive Director
31,165 -7.4%
25.33
US$789,409 		31,165 -7.4% 25.33 US$789,409
2025-11-13 2025-11-12 S Sale
3.7
DE GREEF RODERICK

President and CEO

Executive Director
33,418 -7.4%
25.88
US$864,858 		33,418 -7.4% 25.88 US$864,858
2025-11-12 2025-11-12 PrS Proposed sale
3.1
DuRoss Amy

Director

Non-Executive Director
12,000
26.38
US$316,560 		12,000 26.38 US$316,560
2025-11-12 2025-11-12 PrS Proposed sale
3.7
RODERICK DE GREEF

Officer

Officer
33,418
25.88
US$864,995 		33,418 25.88 US$864,995
2025-11-13 2025-11-11 S Sale
3.7
DE GREEF RODERICK

President and CEO

Executive Director
35,417 -7.2%
26.15
US$926,155 		35,417 -7.2% 26.15 US$926,155
2025-11-12 2025-11-11 PrS Proposed sale
3.7
RODERICK DE GREEF

Officer

Officer
35,417
26.15
US$926,091 		35,417 26.15 US$926,091
2025-10-28 2025-10-24 PlS Planned sale
GOSWAMI JOYDEEP
Non-Executive Director
1,666 -3.6%
28.99
US$48,297 		1,666 -3.6% 28.99 US$48,297
2025-10-24 2025-10-22 PlS Planned sale
3.7
DE GREEF RODERICK

President and CEO

Executive Director
37,795 -7.2%
27.30
US$1,031,804 		37,795 -7.2% 27.30 US$1,031,804
2025-10-22 2025-10-22 PrS Proposed sale
3.7
DE GREEF RODERICK

Officer; Director

Executive Director
37,795
27.30
US$1,031,807 		37,795 27.30 US$1,031,807
2025-10-22 2025-10-20 PlS Planned sale
Werner Sean

Chief Technology Officer

Officer
275 -1.0%
27.82
US$7,650 		275 -1.0% 27.82 US$7,650
2025-10-16 2025-10-16 PrS Proposed sale
GOSWAMI JOYDEEP

Director

Non-Executive Director
9,000
30.99
US$278,910 		9,000 30.99 US$278,910
2025-10-17 2025-10-15 S Sale
3.3
Casdin Partners Master Fund, L.P.
Large shareholder
750,000 -11.2%
28.55
US$21,410,325 		750,000 -11.2% 28.55 US$21,410,325
2025-10-15 2025-10-15 PrS Proposed sale
3.3
Casdin Partners Master Fund, L.P.

10% Shareholder

Large shareholder
750,000
28.55
US$21,410,325 		750,000 28.55 US$21,410,325
2025-10-14 2025-10-09 PlS Planned sale
2.9
Berard Todd

Chief Marketing Officer

Officer
289 -0.2%
27.36
US$7,907 		289 -0.2% 27.36 US$7,907
2025-10-14 2025-10-09 PlS Planned sale
4.0
Wichterman Troy

Chief Financial Officer

Officer
833 -0.5%
27.36
US$22,791 		833 -0.5% 27.36 US$22,791
2025-10-14 2025-10-09 PlS Planned sale
3.4
Mathew Aby J.

EVP & Chief Scientific Officer

Officer
509 -0.1%
27.36
US$13,926 		509 -0.1% 27.36 US$13,926
2025-10-14 2025-10-09 PlS Planned sale
3.6
Aebersold Sarah

Chief Human Resources Officer

Officer
188 -0.2%
27.36
US$5,144 		188 -0.2% 27.36 US$5,144
2025-10-14 2025-10-09 PlS Planned sale
3.0
Foster Karen A.

Chief Quality and Operations

Officer
419 -0.2%
27.36
US$11,464 		419 -0.2% 27.36 US$11,464
2025-09-17 2025-09-15 PlS Planned sale
3.6
Aebersold Sarah

Chief Human Resources Officer

Officer
714 -0.9%
25.61
US$18,286 		714 -0.9% 25.61 US$18,286
2025-09-15 2025-09-15 PrS Proposed sale
3.6
SARAH AEBERSOLD

Officer

Officer
714
25.51
US$18,214 		714 25.51 US$18,214
2025-09-15 2025-09-11 PlS Planned sale
2.9
Berard Todd

Chief Marketing Officer

Officer
358 -0.3%
26.83
US$9,605 		358 -0.3% 26.83 US$9,605
2025-09-15 2025-09-11 PlS Planned sale
3.0
Foster Karen A.

Chief Quality and Operations

Officer
511 -0.3%
26.83
US$13,710 		511 -0.3% 26.83 US$13,710
2025-09-15 2025-09-11 PlS Planned sale
Werner Sean

Chief Technology Officer

Officer
72 -0.3%
26.83
US$1,932 		72 -0.3% 26.83 US$1,932
2025-09-15 2025-09-11 PlS Planned sale
3.6
Aebersold Sarah

Chief Human Resources Officer

Officer
233 -0.3%
26.83
US$6,251 		233 -0.3% 26.83 US$6,251
2025-09-15 2025-09-11 PlS Planned sale
4.0
Wichterman Troy

Chief Financial Officer

Officer
1,032 -0.6%
26.83
US$27,689 		1,032 -0.6% 26.83 US$27,689
2025-09-15 2025-09-11 PlS Planned sale
3.4
Mathew Aby J.

EVP & Chief Scientific Officer

Officer
630 -0.2%
26.83
US$16,903 		630 -0.2% 26.83 US$16,903
2025-08-28 2025-08-26 PlS Planned sale
3.6
Aebersold Sarah

Chief Human Resources Officer

Officer
219 -0.3%
25.44
US$5,571 		219 -0.3% 25.44 US$5,571
2025-08-28 2025-08-26 PlS Planned sale
3.0
Foster Karen A.

Chief Quality and Operations

Officer
413 -0.2%
25.44
US$10,507 		413 -0.2% 25.44 US$10,507
2025-08-28 2025-08-26 PlS Planned sale
3.4
Mathew Aby J.

EVP & Chief Scientific Officer

Officer
531 -0.2%
25.44
US$13,509 		531 -0.2% 25.44 US$13,509
2025-08-28 2025-08-26 PlS Planned sale
2.9
Berard Todd

Chief Marketing Officer

Officer
354 -0.3%
25.44
US$9,006 		354 -0.3% 25.44 US$9,006
Explore more

More insider trading research around Biolife Solutions Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America